Skip to content
value.today
Total raised
$10 M
1 round on record
Latest round
$10 M
Feb 2010
First round on record
Feb 2010
Today
Went public
See the company page

Inogen Inc is listed today as Inogen, Inc.: market value, financials and filings are on its company page.

Funding rounds

1 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of Inogen Inc
MonthRaisedRaiseSizeInvestorsSoldFiling
Feb 2010$10 MNo. 1$2 to $10 million

Inogen Inc: Raise no. 1, Feb 2010

Investors in this round

8 investors had bought by the notice of Jul 13, 2010: 8 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round. 12 investors are named for Inogen Inc as a whole in other filings: see Investors below.

What the notice says

Amount sold
$10 M of $10 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Alison E. Perry · Executive Officer
  • Raymond Huggenberger · Executive Officer, Director
  • Chalres E. Larson · Director
  • Heath Lukatch · Director
  • Shephen E. Cooper · Director
  • William J. Link · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Alison Perry, CFO, VP of Finance. Source: SEC Form D and 1 amendment, newest notice filed Jul 13, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Inogen Inc chose not to state its revenue in its newest notice of a funding round (Jul 2010).

    SEC Form D · Jul 2010

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Jul 2010

That is all the official record says: Inogen Inc has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services of Inogen Inc are on record.

Investors#

12 named in official filings. Open an investor to see everything it has backed.

Investors in Inogen Inc
InvestorKindAmountRoundRoleSource
Arboretum Investment Manager IIa, LLCFund or asset managernot statednot statedHeld Series D, E, F and G preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Arboretum Investment Manager II, LLCFund or asset managernot statednot statedHeld Series D, E, F and G preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Arboretum Investment Manager, LLCFund or asset managernot statednot statedHeld Series D, E, F and G preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Arboretum Ventures 11a LPVenture capitalnot statednot statedHeld Series D, E, F and G preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Arboretum Ventures 1-A, LLCVenture capitalnot statednot statedHeld Series D, E, F and G preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Arboretum Ventures II LPVenture capitalnot statednot statedHeld Series D, E, F and G preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Arboretum Ventures, LLCVenture capitalnot statednot statedHeld Series D, E, F and G preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Novo Holdings A/sFund or asset managernot statednot statedHeld Series B, C, D, E, F and G preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Versant Affiliates Fund II-A, LPFund or asset managernot statednot statedHeld Series B, C, D and E preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Versant Side Fund II, LPFund or asset managernot statednot statedHeld Series B, C, D and E preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Versant Venture Capital II, LPVenture capitalnot statednot statedHeld Series B, C, D and E preferred stock, 10% owner (Form 3, 2014)SEC Form 3
Versant Ventures II LLCVenture capitalnot statednot statedHeld Series B, C, D and E preferred stock, 10% owner (Form 3, 2014)SEC Form 3

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 1 round above had up to 8 investors.

Largest shareholders today

Institutions holding Inogen, Inc. shares, as of Sep 30, 2026.

Source: SEC Form 13F holdings reports · as of Sep 30, 2026. Value held and share of the company. All holders are on the company page.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Inogen Inc
NameRoleNamed in
Alison E. PerryExecutive officerJul 2010
Raymond HuggenbergerExecutive officerJul 2010
Chalres E. LarsonDirectorJul 2010
Heath LukatchDirectorJul 2010
Raymond HuggenbergerDirectorJul 2010
Shephen E. CooperDirectorJul 2010
William J. LinkDirectorJul 2010

Went public since 2014. Its SEC number is that of a company listed on a stock exchange.